Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2004 Dec;4(6):441-6.
doi: 10.1007/s11892-004-0054-0.

Clinical studies of advanced glycation end product inhibitors and diabetic kidney disease

Mark E Williams  1
Affiliations
Review

Clinical studies of advanced glycation end product inhibitors and diabetic kidney disease

Mark E Williams. Curr Diab Rep. 2004 Dec.

Abstract

Current treatment of the nephropathy complication of diabetes mellitus is suboptimal in halting the progression of the complex disease. Among the irreversible effects of sustained hyperglycemia is the heightened formation of advanced glycation end products (AGEs). The role of AGEs in diabetic nephropathy has been established by years of basic research. This article reports progression through human studies of the few AGE inhibitors that have reached clinical development, including pimagedine, pyridoxamine, and alagebrium.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Am J Kidney Dis. 2000 Mar;35(3):365-80 - PubMed
    1. Lancet. 1980 Apr 5;1(8171):738-40 - PubMed
    1. Metabolism. 2002 Jul;51(7):901-5 - PubMed
    1. J Lab Clin Med. 2003 Apr;141(4):242-9 - PubMed
    1. Arch Biochem Biophys. 2003 Nov 1;419(1):41-9 - PubMed

MeSH terms

LinkOut - more resources